Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30014441
Basic Information
VIS ID
TVIS30014441
Fusion event
HIV-C2CD2L integration
Validated
Yes
Detection method
invPCR
Data source
download(RID)
Sample type
PBMC
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2007
PubMed ID
17262715
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr11
Cytoband
q23.3
Reference genome
GRCh37/hg19
Start
118981923/119111213 (Hg38)
End
118981923/119111213 (Hg38)
Orient
+
Location type
Intronic
Fragile sites / regions
FRA11B
Target gene
C2CD2L
miRNAs that regulate target gene
hsa-mir-6809-3p
;
hsa-mir-6833-3p
;
hsa-mir-4768-5p
;
hsa-mir-6818-3p
;
hsa-mir-3191-5p
;
hsa-mir-525-5p
;
hsa-mir-520a-5p
;
hsa-mir-593-3p
;
hsa-mir-6895-3p
;
hsa-mir-6829-3p
;
hsa-mir-6791-3p
;
hsa-mir-6823-3p
;
hsa-mir-2114-3p
;
hsa-mir-1236-3p
;
hsa-mir-6515-3p
;
hsa-mir-6728-3p
;
hsa-mir-5699-3p
;
hsa-mir-4421
;
hsa-mir-6748-3p
;
hsa-mir-660-3p
;
hsa-mir-1-5p
;
hsa-mir-501-5p
;
hsa-mir-508-5p
;
hsa-mir-3145-5p
;
hsa-mir-27a-3p
;
hsa-mir-27b-3p
Nearest miRNA
hsa-mir-10392/Upstream/200426; hsa-let-7a-2/Downstream/201737;
Nearest TSS
ENST00000527297/Upstream/156;
ENST00000533458/Downstream/348;
Nearest CpG islands
None/Target,
chr11-CpG: 30/Upstream/3138
,
chr11-CpG: 72/Downstream/9963
Upstream sequence
CACCCAGCCAGCCATGATGGTCAACCTCAGGGCTTGCTCTGCCCCAGGAGGCCTGGTGAGTTGGCACCCAAAGCAAAAGATTTGCATGCACCTTGTTCCT
Downstream sequence
AGGGTGCTATGTCAGGATTCTTGCTCTTTGGACCTTCTTCTGCTCTTAGGTACCCAGTGAGAAGCCACCCATGATGCCCCAGGCTCAGCCAGCCATCCCC
Reference
Ikeda, T., et al. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy. J Infect Dis,2007, 195(5): 716-725.
Sample Information
×
Sample type
PBMC
Gender
Female
CpG Island Information
×
Download
Curate